Patients with multiple sclerosis are joining together to fund research that they find promising.
Naltrexone is a drug, an opioid receptor antagonist, which is sometimes used for treating addictions. Naltrexone was discovered 20+ years ago, so is off-patent, and therefore no longer highly profitable nor of interest to large drug companies. Low Dose Naltrexone (LDN) was anecdotally found to be helpful for treating multiple sclerosis. A number of MS patients banded together, forming their own research group to review current knowledge and direct studies. They held a fund raising benefit; the $25,000 proceeds were awarded to UCSF to conduct a small, double-blind, cross-over trial this spring, according to LDNers. Sounds like a carefully designed study. Way to go!
The folks at "accelerated cure" also have a terrific brochure on working with MS. This handy booklet gives lots of suggestions for dealing with workplace issues that are applicable to those with any chronic disease.
Wired Space Photo of the Day: Galactic Wheels
22 hours ago